CIK: 1231615 - Address: 419 Davis Drive, Suite 100, Morrisville, NC 27560
11 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

4/16/24 17:15
4/12/24
LQDALiquidia CorpDEHealthDrugPharmaceutical PreparationsJeffs RogerNCDOCEOS-12214.580-802,415D
3/19/24 21:46
3/18/24
LQDALiquidia CorpDEHealthDrugPharmaceutical PreparationsJeffs RogerNCDOCEOS-45215.820-29-12,424D
3/15/24 20:05
3/14/24
AXSMAxsome Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsJeffs RogerNYDM.dm79024.4403224168D
3/15/24 20:05
3/14/24
AXSMAxsome Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsJeffs RogerNYDS.dm-2,25769.840-32-16168D
12/18/23 17:02
12/14/23
LQDALiquidia CorpDEHealthDrugPharmaceutical PreparationsJeffs RogerNCDOCEOP1,0007.16014072,229D
1/5/23 17:35
1/3/23
LQDALiquidia CorpDEHealthDrugPharmaceutical PreparationsJeffs RogerNCDOCEOM.d00.0001611,796D
10/4/22 16:25
10/3/22
LQDALiquidia CorpDEHealthDrugPharmaceutical PreparationsJeffs RogerNCDOCEOM.d00.0004731,796D
9/7/22 20:14
9/6/22
LQDALiquidia CorpDEHealthDrugPharmaceutical PreparationsJeffs RogerNCDOCEOP2445.5704431,748D
9/1/22 20:36
8/31/22
LQDALiquidia CorpDEHealthDrugPharmaceutical PreparationsJeffs RogerNCDOCEOP54.900101,704D
5/25/22 19:27
5/24/22
LQDALiquidia CorpDEHealthDrugPharmaceutical PreparationsJeffs RogerNCDOCEOP993.5302821,703I
11/23/21 07:30
11/19/21
AXSMAxsome Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsJeffs RogerNYDP14737.30042168D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact